Fresh Outbreak Of Ebola In Guinea

NEW EBOLA

Health workers are rushing to the site of a fresh Ebola outbreak in Guinea to bolster efforts to contain the virus and prepare for the likelihood of more cases, aid agencies said on Friday.

Four people in the southern region of Nzerekore were tested on Thursday and two of them were found to have Ebola. They were all from Korokpara, a village where three people from the same family have died in recent weeks from diarrhea and vomiting.

The World Health Organisation (WHO) and aid agencies have sent experts to investigate the origin of the new cases and to identify, isolate, vaccinate and monitor all of their contacts.

The Alliance for International Medical Action (ALIMA) has reopened its Ebola treatment unit in Nzerekore, while the United Nations children’s agency (UNICEF) is reinforcing its team in the region and providing protective equipment and medicine.

“There has been a very professional and experienced response across the board,” said Augustin Augier of ALIMA, which admitted the two patients, a child and his mother, to its treatment unit.

“We are doing all we can to be ready to receive more cases,” he said, adding that ALIMA were flying in more staff from Paris.

More than 28,500 people have been infected and 11,300 have died since the world’s worst recorded Ebola epidemic began in December 2013 – mostly in Guinea, Liberia and Sierra Leone.

While the epidemic has come under control, experts have warned of the risk of new flare-ups, as Ebola can linger in the eyes, central nervous system and bodily fluids of survivors.

The two fresh cases in Nzerekore, where the Ebola outbreak began in 2013, were reported just hours after the WHO declared neighboring Sierra Leone’s latest flare-up over.

Guinea had been nearing the end of a 90-day period of heightened surveillance when the fresh cases were reported – the country’s first known re-emergence of Ebola after the outbreak was officially declared over there at the end of December 2015.

“The heightened surveillance means mechanisms were in place and that we were vigilant and prepared to deal with the flare-up,” said Guy Yogo, UNICEF’s deputy representative in Guinea.

“The population is now aware of the disease and listening to the guidance it receives from the authorities,” Yogo added.

It was not immediately clear how the villagers from Korokpara had contracted Ebola but the area had resisted efforts to fight the disease in the initial epidemic.

(Reporting By Kieran Guilbert, Editing by Ros Russell; Please credit the Thomson Reuters Foundation, the charitable arm of Thomson Reuters, that covers humanitarian news, women’s rights, trafficking, corruption and climate change. Visit news.trust.org)

HOW EBOLA KILLS 

The question the world needs an answer: If Aids and Ebola are not bio-weapons against Africa, why the disease keeps emerging after the World Health Organization and Center for Diseases Control declared Liberia, Guinea and Sierra Leone Ebola free countries?

“You can fool all the people some of the time, and some of the people all the time, but you cannot fool all the people all the time.” – Abraham Lincoln.

Valentine’s Day Special: How Inexperienced Love Life, Moulded To Love Only One Woman

adore 5At school, while very young, I heard of the word ‘Womanizer.’ I had no idea what that means, so I took the dictionary and read ” A man who likes many women and has short sexual relationships with them.” I said to myself, that’s not the way I would like to live, especially in those days when Gonorrhea is very common.

At 19, I was still a celibate and hadn’t tasted the ‘golden apple,’ yet, surprisingly, I had no desire to find out how ‘delicious or sour it may be.’ I often hear some of my friends, talking about their girlfriends, and wonder how they had them.

Without even searching for a girlfriend, I had one during school athletics competition. Extremely beautiful dark complexioned girl called Esther. Any time she puts her hand around my neck, I feel something in my breast pocket. It was money.

I was just proud to have a girlfriend and I spoke about her to my classmates, but very green, I didn’t give her what often happens when a door is closed behind a man and a woman. After Esther, came Lydia. She was actually the first girl who thought me how to do it at the age of twenty. The contents of her love letters made me to believe that she graduated from a ‘Love School.’

When I saw her naked body, I gazed at her like Adam gazing at ‘The Apple of Temptation’ on the tree. She laid down and I took my position. But inexperienced Joe was just on top of her motionless, waiting for a miracle to take place . She then asked me to jerk my body up and down.

After following her instructions, I started feeling something unusual flowing through my body like electric current. This unusual feeling is hard to describe. Like one under a trance, I don’t think I would have got the energy to escape if a charged elephant or a wild lion is coming my way. After some few minutes, I felt like I’m in a perfect place of  happiness, paradise. I wasn’t aware that this inexperienced love life is going to help me one day.

From there on, struggling to be a man was my priority, than having a girlfriend, until I got married in my thirties. After marriage, I realized the importance, gem and quality of a woman. The long years without a woman moulded me to treasure my wife, making it totally impossible to love any woman apart from her.

To many, cheating is the best part of relationship, because it’s nice to taste different kinds of food. But just as a man gets food poisoning and diarrhea after eating contaminated food, the same way a man can expose himself to sexually transmitted diseases, then wished you had never done, but it’s too late.

There are many ways to adore your girlfriend or partner for ever. Whenever you’re watching an interesting film or program on the television, don’t lose all your interest to the program. Steal a minute to look at your man or woman. He or she will ask you: Why are you looking at me like that? “I love you,” say to him or her.

Little things in life improve relationship than being rich. There are many domestic activities. Share those responsibilities with your partner. If she does the laundry, do the pressing and if she does the shopping, surprise her with a delicious breakfast preparations. Above all try to maintain respect and remain faithful to each other, even though to err is human.

A Historical Look At The First Report of Lassa, An Ebola like Virus As Biological Warfare Product Against Africa

Lassa 5

By Johan van Dongen and Joel Savage

Lassa fever, an arena-virus, is an acute viral illness that typically occurs in blacks in West Africa. But why? The illness was discovered in 1969 when two missionary nurses died in Nigeria, according to the Center for Diseases Control. But again why? How trustworthy is the CDC?

Lassa fever or Lassa hemorrhagic fever (LHF) is an acute viral hemorhagic fever caused by the Lassa virus and first described in 1969 in the town of Lassa, in Borno State, Nigeria. Lassa fever is a member of the Arenaviridae virusfamily. Similar to Ebola clinical cases of the disease had been known for over a decade but had not been connected with a viral pathogen. The infection is endemic in West African countries, resulting in 300,000 -500,000 cases annually, causing approximately 5,000 deaths each year. Outbreaks of the disease have been observed in Nigeria, Liberia, Sierra leone, Guinea and the Central African Republic.

History of Lassa Fever

There are seven exotic diseases of concern. Three of these, the most unpredictable are Lassa fever, Marburg-virus and Ebola virus diseases. In this article the epidemiologic and bio-warfare aspects of these diseases are discussed, with particular emphasis on exportation from their indigenous areas in Africa and on the occurrence of secondary cases. Any of these conditions fore instance could be brought into Canada, the United States of America, Belgium or the Netherlands either by aero-medical evacuation or inadvertently.

Between 1972 and 1978 there were seven occasions when Canada could have been involved with handling cases of Lassa fever an Ebola like virus. The Government of Canada has purchased several containment bed and transit isolators. These units, with filtered air under negative pressure, accommodate infectious patients being transported and cared for without contaminating medical attendants or the environment. In casu quo under Ebola laboratory conditions.

The latest Lassa Fever patient

A New Jersey patient traveled from Liberia to Morocco to JFK International Airport on May 17th, 2015. The patient did not have a fever on departure from Liberia and did not report symptoms such as diarrhea, vomiting, or bleeding during the flight, according to the CDC.

His temperature was taken on arrival in the U.S. and he did not have a fever at that time. One day later on May 18th, the patient went to an undisclosed hospital in New Jersey with symptoms of a sore throat, fever and tiredness, according to the CDC.

According to the hospital, he was asked on May 18th about his travel history and he did not indicate travel to West Africa. The patient was sent home the same day and on May 21st returned to the hospital when symptoms worsened, according to the CDC.

The plaque reduction neutralization test (PRNT) has been used routinely in serological studies with such arena-viruses

The first scientific publication about the Lassa virus, an Ebola like virus, is written by C. Armstrong in 1934; “Experimental lymphotropic chorio meningitis of monkeys and mice produced by a Lassa virus encountered in studies of the 1933 St. Louis Enchephalitis Epidemic, Public Health Rep. 49: 1019 -1027 (1934).

The mentioned scientific plaque reduction neutralization tests (PRNT) in 1933, used in the forties of the last century and long time before the first outbreak in 1969 in Lassa, Nigeria, to us was the first indication that the biological warfare scene did experiments in Africa in order to look for a biological warfare product.

Nowadays Lassa fever is an acute and sometimes severe viral hemorrhagic illness endemic in West Africa. One important question regarding Lassa fever is the duration of immunoglobulin G (IgG) antibody after infection. We were able to locate three people who worked in Nigeria dating back to the 1940’s, two of whom were integrally involved in the early outbreaks and investigations of Lassa fever in the late 1960’s, including the person from whom Lassa virus was first isolated. Two persons had high titer of Lassa virus-specific IgG antibody over 40 years after infection, indicating the potential for long-term duration of these antibodies. One person was likely infected in 1952, 17 years before the first recognized outbreak.

Background of Lassa virus

Though first described in 1934 and later in the 1940’s and 1950’s, the virus causing Lassa disease was not publicly and officially identified until 1969. The virus is a single-stranded RNA virus belonging to the virus family Arenaviridae.  . Normally about 80% of people who become infected with Lassa virus have no symptoms. One in five infections result in severe bleeding disease, where the virus affects several organs such as the liver, spleen and kidneys.

It is said that normally Lassa fever is a zoonotic disease, meaning that humans become infected from contact with infected animals. The animal reservoir, or host, of Lassa virus is a rodent of the genus Mastomys, commonly known as the “multimammate rat.” Mastomys rats infected with Lassa virus do not become ill, but they can shed the virus in their urine and faeces.

But these rats were infected by scientists, such as Cooper in 1961 and many others before in laboratory models and then set free in the the environment of for instance Lassa, Nigeria, to be precise on blacks in Africa, in order to look after the effects.

Because the clinical course of the disease is so variable, detection of the disease in affected patients has been difficult and that’s why it can be used as a biological warfare agent. However, when presence of the disease is confirmed in a community, prompt isolation of affected patients, good infection protection and control practices and rigorous contact tracing can stop outbreaks.

NOTES:

Ebola like viruses existed long before the first outbreaks in laboratory condition.

  • The first scientific publication about the Lassa virus is written by C. Armstrong in 1934.
  • The first official Ebola like outbreak appears At Marburg University in 1967 in Germany.
  • Though first described in 1934 and later in the 1940’s and 1950’s, the virus causing Lassa disease was not publicly identified until 1969.
  • Mastomys, commonly known as the “multimammate rat.” Mastomys rats infected with Lassa virus do not become ill, but they can shed the virus in their urine and faeces.
  • Because the clinical course of the disease is so variable, detection of the disease in affected patients has been difficult and that’s why it can be used as a biological warfare agent.
  • When presence of the disease is confirmed in a community, prompt isolation of affected patients, good infection protection and control practices and rigorous contact tracing can stop outbreaks.

The Lassa virus plaque assay satisfied the criteria proposed by Cooper in 1961 for determining satisfactory plaque technique

The plaque reduction neutralization test (PRNT) has been used routinely in serological studies with such arenaviruses as Junin, Machupo, and Parana. However, difficulties have been encountered in using the PRNT for Lymphocytic choriomeningitis virus LCM, while conflicting views have been expressed about the reliability and efficacy of the test with Lassa virus. They therefore investigated and evaluated the plaque assay for Lassa virus. In addition, the suitability of the PRNT for determining the potency of a serum and its efficacy in passive immunization for the treatment of Lassa fever was also investigated.

Questions:

How long can Center for Diseases Control and World Health Organization continue to fool the world and Africans? How is it possible that the Lassa virus known in the thirties, forties and fifties in laboratory circumstances, be officially known after outbreak in 1969 in Lassa town in Nigeria?

Answer:

Because it is a secret biological warfare product developed by the Nazis. Later, after the Second World War, the biological warfare product Ebola, was improved under the guidance of Nazi scientists in the United States of America as described in: “Aids and Ebola the greatest crime in medical history against mankind” amazon.com.

The domination of man to subdue others and greed, have caused much destruction in this world. People don’t care about the truth any longer, but we should always remember that when the rain falls, it doesn’t fall on one man’s roof, every health catastrophe or pandemic could easily spread to every part of this world, through terrorism when it falls into wrong hands. What happened on September 11 unexpectedly, should be a lesson for the media to start unfolding the truth about the origins of  Aids and Ebola and bring those responsible to face justice.

Pharmaceutical Disease Producing Factories Administered Dangerous Isoniazide And Sulfadiazide To Spread Tuberculosis

“Pharmaceuticals Companies Make Business With Intentionally Created Diseases In Africa”- Professor Johan Van Dongen.

Johan 2

Professor Johan Van Dongen, the former Micro-Surgeon.

According to the German scientist Wolff Geisler, thousands of Aids patients affected with tuberculosis in Africa, are not caused by the HIV virus. In my opinion he is right, because the increase of the number of tuberculosis patients in Africa, is a result of intended spread of the disease through dangerous medicines like Isoniazid and Sulfadianozide , given to Africans in tuberculosis clinics in African countries, such as Burundi, the former Belgian Congo, Uganda and Zambia. Instead of curing, the two mentioned medicines rather cause a tremendous acceleration of HIV infections amongst African people.

The WHO/IUATLD Working Group And Wolff Geisler

In 1989, the WHO/IUATLD working group declared in the “Bulletin International Union Tuberculosis Lung Disease” that HIV in TB-hospitals could have been spread as a result of unhygienic anti-tuberculosis injections, but as a former micro-surgeon, I, Johan van Dongen challenge them to prove that statement.

Again according to Wolff Geisler, remarkably horrendous numbers of HIV-infections originate only from US American or British financed and managed hospitals in the respectively mentioned countries. For instance in hospitals in Kitgum and Kagando in Uganda (where there was no recognizable USA or British finance), 10% of the TB patients, normally an average of 15% of the total population were HIV infected.

Aids Causing Factories

According to the World Health Organization, in Africa 17-55% of TB patients have HIV-antibodies. The WHO expert Slutkin mentioned 30-60% in some of the developing countries, a clear sign of intentional infection of tuberculosis patients in Zambia with HIV. The same evidence was provided by the same expert in the Chinkala Hospital, TB patients Mazubuku. 23% of the TB patients in the middle of 1987 were also infected with HIV.

Six months later, the virus was located in 50% of patients within the same hospital, after administering Isoniazid and Sulfadiazide. The same figures slightly increased in 58% of TB patients in Ndola, and in 60% of TB patients in the University Teaching Hospital in Lusaka, Zambia.

In the Makalala Sanatorium in Kinshasa, Zaire, 33% of TB patients had HIV antibodies (among the staff: 4-8%), and in Chinkankata 36%. In Malawi, 50-66% of TB patients also had HIV antibodies. In the TB clinic, Centre Anti Tuberculeux de Bujumbura in Burundi, 55% of TB patients were HIV-infected in 1986, and in the Mwanza region of Tanzania, 25% of TB patients had HIV-antibodies. Moreover, the patients were treated with forbidden drugs, because in New York, 1972, about 21 people who were taking intravenous agents had succumbed to inexplicable tuberculosis before 1972.

Already written in a previous article, in contrast, patient with a cellular deficiency hypersensitivity following the polio- and cowpox vaccinations, are particularly prone to certain bacterial, viral and protozoal infections caused by Mycobacterium tuberculosis TB. And then the pharmaceutical disease producing factories appear by using deadly toxic agents such as Isoniazid, produced by Teva Netherlands BV (Holland, and Sulfadiazide, produced by Pfizer in Germany.

What Is Tuberculosis?

Tuberculosis is a chronically infectious disease which generally affects the lungs. The causing agent, tubercle bacilli, is mostly passed on from person to person through coughing of droplets from the respiratory tract (lungs), and can also be transmitted onto the skin, eyes of persons in the immediate vicinity. Tubercles also can penetrate the body through drinking.

A striking phenomenon! Side Effects Of Isoniazid And Sulfadiozanide.

Hospitals, including Mbare Hospital in Harare, were suddenly full of tuberculosis patients and the people were suffering from venereal diseases at the same time, as a side effect consequence, because Isoniazid and Sulfadiazide made them susceptible for these. It is obvious that Isoniazid and Sulfadiazide are the cause of these venereal diseases because it appears in almost all infected children under the age of ten.

As described before, in Africa tuberculosis and HIV go hand in hand, but the mass spread of tuberculosis infections in Africans with Aids is not caused by HIV-infection at all. The increase in the number of African TB patients is the result of intended spread of special tuberculosis agents, and patients treated with Sulfadiozanide and Isoniazid at the end caught Aids!

Disease Factories Using Isoniazid And Sulfadiozanide

The two medicines, Isoniazid and Sulfadiazide, shouldn’t have been used as medications against TB and most certainly not in Aids patients. Only the long list of side effects gives you the shivers. Therefore we will describe a list with side effects causing a huge amount of invented new diseases in order to sell more medicines against these side effects……

TB 3

Tuberculosis patients in a hospital.

Side Effects Caused By Isoniazid And Sulfadiazide There we go! And We Are starting With:

“Anxiety, blurred vision, changes in menstrual periods, chills, cold sweats, coma, confusion, cool, pale skin, decreased sexual ability in males, depression, dizziness, ‘dry’ puffy skin, fast heartbeat, feeling cold, headache, increased hunger, nausea, nervousness, nightmares, seizures, shakiness, slurred speech, swelling of front part of the neck, unusual tiredness or weakness and last but not least: weight gain.”

There You Have It. And If You Think This List Of Side Effects Is Completed, Not at all! There Is More: Let’s continue:

“Abdominal or stomach pain, back- leg- or stomach pains, ‘black’ tarry stools, bleeding gums, bleeding under the skin, blindness or vision changes, “blistering, peeling, or loosening” of the skin, bloating, blood in the urine or stools, “bluish-colored lips, fingernails or palms”, burning of the face or mouth, –burning, crawling, itching, numbness, painful, prickling, “pins and needles”, or tingling feelings–, chest pain, cloudy urine, clumsiness or unsteadiness.

Constipation, continuing ringing or buzzing or other unexplained noise in the ears, cough or hoarseness, cracks in the skin, darkened urine, decrease in the amount of urine, diarrhea, difficulty with breathing, difficulty with moving, dizziness or lightheadedness, feeling of discomfort, fever with or without chills, general body swelling, general feeling of tiredness or weakness, headache, hearing loss.

Indigestion, itching- joint or muscle pain, light-colored stools, loss of appetite and weight, loss of heat from the body, lower back or side pain, muscle pain or stiffness, nosebleeds, not able to pass urine, pain or burning while urinating, painful or difficult urination, “pains in the stomach side or abdomen and possibly radiating to the back”, pale skin, pinpoint red or purple spots on the skin, rapid heart rate, rash, “red skin lesions often with a purple center.”

Red irritated eyes, red swollen skin, redness of the white part of the eyes, scaly skin, “seeing, hearing, or feeling things that are not there”, seizures, shakiness and unsteady walk, shortness of breath, sore throat, soreness of the muscles, sores, ulcers, or white spots on the lips or in the mouth, sudden decrease in amount of urine, swelling around the eyes.

“Swelling of the face, hands, legs, and feet”, swelling or inflammation of the mouth, swollen lymph glands, swollen or painful glands, tightness in the chest, “unsteadiness, trembling, or other problems with muscle control or coordination”, unusual bleeding or bruising, upper right abdominal pain, vision changes, vomiting, weakness in the hands or feet, wheezing, yellow eyes or skin.”

“Some side effects do not need medication, because of fear, you will pay a visit to a doctor, you have to pay consultation fee, you also have to pay for the prescription and medicines and together we pay billions of dollars to the pharmaceutical industry, and  in turn they pay scientists, pharmacists and everybody else who wants to be paid in order to sell medicines for causing the above-mentioned side effects for the production of diseases.”

Pharmacists, Doctors And Scientist Paid By The Pharmaceutical Industry

Some Sulfadiazine side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects but do check with them if any of the following side effects continue, or if you are concerned about them.

And for each and every one of these checks, because of side effects you will pay a visit to a doctor, you have to pay for the consultation fee, you also will have to pay for the prescription and medicines and together we pay billions of dollars to the pharmaceutical industry and the pharmaceutical industry pay scientists, pharmacists and everybody else, who wants to be paid in order to sell medicines for causing the above-mentioned side effects for the production of diseases.

Incidence Side Effects Not known

Feeling of constant movement of self or the surroundings, hives or welts, the sensation of spinning, restlessness, and trouble with sleeping.

Healthcare Professionals Applies To Sulfadiazine: Compounding Powder, Oral Tablet Causing Hypersensitivity

Hypersensitivity side effects include urticarial rash (most common), allergic myocarditis, anaphylactoid reactions, anaphylaxis, arthralgia, conjunctival and scleral injection, drug fever and chills, epidermal necrolysis, erythema multiforme, exfoliative dermatitis, generalized skin eruptions, periorbital edema, photosensitization, serum sickness, Stevens-Johnson syndrome, and urticaria.

The use of sulfonamide antibiotics, including sulfadiazine, is associated with large increases in the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis, although these phenomena are rare as a whole.

Hematologic

Hematologic side effects include agranulocytosis (0.1%), aplastic anemia, hemolytic anemia (0.05%), hypoprothrombinemia, leukopenia, methemoglobinemia, and purpura. Hemolytic anemia occurs less often with sulfadiazine than with other sulfonamides. Aplastic anemia may be more likely in patients with poor bone marrow reserves.

Gastrointestinal Side Effects

Gastrointestinal side effects include nausea, vomiting, abdominal pain, diarrhea, anorexia, pancreatitis, and stomatitis.

Hepatic Side Effects

Hepatic side effects are rare but can be serious. Isolated cases of hepatitis and jaundice due to cholestasis have been associated with sulfadiazine. Elevated liver function tests (with a negative hepatitis panel) have been reported in at least one case associated with psychosis.

Psychiatric Side Effects

Psychosis associated with Sulfadiazine and Pyrimethamine therapy in patients with AIDS and CNS toxoplasmosis has been described in two separate case reports. In each case, tremulousness and disorientation developed within three days to two weeks after starting therapy, despite partial resolution of the size of the intracranial T Gondii lesions. No other obvious cause for mental status changes was found.

The delirium resolved upon discontinuation of therapy in each case and was reproducible upon re-challenged. In one case, the patient had elevated liver function tests (hepatitis panel was negative), which were reversible upon discontinuation of therapy. Psychiatric side effects include frank psychosis in patients with AIDS and CNS toxoplasmosis. Tremulousness, disorientation, and delirium have been reported.

Nervous System Side Effects

Nervous system side effects include ataxia, convulsions, hallucinations, headache, insomnia, mental depression, peripheral neuritis, tinnitus, and vertigo.

Renal Side Effects

Renal side effects include crystalluria, lupus erythematosus, periarteritis nodosa, toxic nephrosis with oliguria and anuria, and acute renal failure secondary to crystalluria or tubulointerstitial nephritis.

Genitourinary Side Effects

In one case, analysis of the stone fragments showed a composition of 100% acetylated 2-sulfanilamidopyrimidine, a metabolite of sulfadiazine.

Genitourinary side effects include urolithiasis.

Metabolic Side Effects

Metabolic side effects have included hypoglycemia.

Endocrine side effects

Endocrine side effects associated with sulfonamides have rarely included diuresis, goiter production, and sialadenitis.

If you swallow Isoniazid and Sulfadianozide or AZT as mentioned in one of our previous articles, then you are a lunatic.

References:

  1. Tenant-Flowers M, Boyle M, Carey D, et al “Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis.” AIDS 5 (1991): 311-5
  2. Finland M, Strauss E, Peterson O “Sulfadiazine.” JAMA 251 (1984): 1467-74
  3. Robson M, Levi J, Dolberg L, Rosenfeld J “Acute tubulointerstitial nephritis following sulfadiazine therapy.” Isr J Med Sci 6 (1970): 561-
  4. Finland M, Strauss E, Peterson O “Sulfadiazine.” JAMA 116 (1941): 2641-7
  5. Goadsby P, Donaghy A, Lloyd A, Wakefield D “Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure.” Ann Intern Med 107 (1987): 783-4
  6. Pisanty S, Brayer L “Erythema multiforme-like eruption due to sulfadiazine.” J Dent Med 20 (1965): 154-7
  7. Roujeau JC, Kelly JP, Naldi L, et al. “Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.” N Engl J Med 333 (1995): 1600-
  8. “Product Information. Sulfadiazine (sulfadiazine).” Eon Labs Manufacturing Inc, Laurelton, NY.
  9. Carbone L, Bendixen B, Appel G “Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome.” Am J Kidney Dis 12 (1988): 72-5
  10. Carrion-Carion C, Morales-Suarez-Varela MM, Llopis-Gonzalez A “Fatal Stevens-Johnson syndrome in an AIDS patient treated with sulfadiazine.” Ann Pharmacother 33 (1999): 379
  11. Kounis GN, Kouni SA, Chiladakis JA, Kounis NG “Comment: Mesalamine-Associated Hypersensitivity Myocarditis in Ulcerative Colitis and the Kounis Syndrome (February).” Ann Pharmacother 43 (2009): 393-4
  12. Iaccheri B, Fiore T, Papadaki T, et al. “Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review.” Clin Ther 30 (2008): 2069-74
  13. Puckett J, Cooper M, Stuart J, Wu WC, Sterchi JM “Pyrimethamine, sulfadiazine, and villous atrophy of the jejunum.” Ann Intern Med 96 (1982): 380
  14. Reboli AC, Mandler HD “Encephalopathy and psychoses associated with sulfadiazine in two patients with AIDS and CNS toxoplasmosis.” Clin Infect Dis 15 (1992): 556-7
  15. Young C “Acute encephalopathy associated with sulfadiazine in a patient with AIDS-related complex.” J Infect Dis 160 (1989): 163-4
  16. Dusseault BN, Croce KJ, Pais VM Jr “Radiographic characteristics of sulfadiazine urolithiasis.” Urology 73 (2009): 928.e5-6
  17. Crespo M, Quereda C, Pascual J, Rivera M, Clemente L, Cano T “Patterns of sulfadiazine acute nephrotoxicity.” Clin Nephrol 54 (2000): 68-72
  18. Schuler AK, Talor Z “The case: 69-year-old man, with sand in the urine. N-acetyl sulfadiazine crystals.” Kidney Int 72 (2007): 769-70
  19. Perazella MA “Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity.” Am J Med Sci 325 (2003): 349-62
  20. Marques LPJ, Madeira EPQ, Santos OR “Renal alterations induced by sulfadiazine therapy in an AIDS patients.” Clin Nephrol 42 (1994): 68-9
  21. Anibarro B, Fontela JL “Sulfadiazine-induced sialadenitis.” Ann Pharmacother 31 (1997): 59-60

http://www.amazon.com/AIDS-EBOLA-Greatest-Medical-History-ebook/dp/B00QZCYMSS/